Variant report

Variant	nsv876022
Chromosome Location	chr2:234726154-234748814
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:628)
CpG islands
(count:244)
Chromatin interactive
region (count:24)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:628 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:234741557-234741726	HepG2	liver:	n/a	n/a
2	ATF3	chr2:234740876-234742388	A549	lung:	n/a	n/a
3	ATF3	chr2:234741378-234742011	A549	lung:	n/a	n/a
4	BCL3	chr2:234739080-234744341	A549	lung:	n/a	chr2:234741660-234741669
5	BCL3	chr2:234739349-234744830	A549	lung:	n/a	chr2:234741660-234741669
6	CCNT2	chr2:234744492-234744660	K562	blood:	n/a	n/a
7	CCNT2	chr2:234741414-234741879	K562	blood:	n/a	n/a
8	CEBPB	chr2:234731924-234732267	HepG2	liver:	n/a	n/a
9	CEBPB	chr2:234741419-234741715	Hela-S3	cervix:	n/a	n/a
10	CEBPB	chr2:234741103-234741767	A549	lung:	n/a	n/a
11	CEBPB	chr2:234741497-234741689	HepG2	liver:	n/a	n/a
12	CEBPB	chr2:234731899-234732266	A549	lung:	n/a	n/a
13	CEBPB	chr2:234731947-234732262	Hela-S3	cervix:	n/a	n/a
14	CEBPB	chr2:234741111-234742470	A549	lung:	n/a	n/a
15	CEBPB	chr2:234745485-234745497	A549	lung:	n/a	n/a
16	CEBPB	chr2:234731812-234732248	A549	lung:	n/a	n/a
17	CEBPB	chr2:234731937-234732232	MCF-7	breast:	n/a	n/a
18	CEBPB	chr2:234741081-234741741	IMR90	lung:	n/a	n/a
19	CEBPB	chr2:234731930-234732212	IMR90	lung:	n/a	n/a
20	CEBPB	chr2:234731890-234732263	HepG2	liver:	n/a	n/a
21	CEBPB	chr2:234740881-234743005	A549	lung:	n/a	chr2:234742787-234742799
22	CHD2	chr2:234744120-234744308	K562	blood:	n/a	n/a
23	CHD2	chr2:234741623-234741690	HepG2	liver:	n/a	n/a
24	CHD2	chr2:234743549-234743596	K562	blood:	n/a	n/a
25	CHD2	chr2:234748223-234748274	GM12878	blood:	n/a	n/a
26	CREB1	chr2:234741379-234742354	A549	lung:	n/a	n/a
27	CREB1	chr2:234744421-234744685	A549	lung:	n/a	n/a
28	CREB1	chr2:234741471-234741937	A549	lung:	n/a	n/a
29	CTCF	chr2:234741534-234741743	GM19240	blood:	n/a	chr2:234741633-234741641
30	CTCF	chr2:234741520-234741670	HEK293	kidney:	n/a	chr2:234741633-234741641
31	CTCF	chr2:234741500-234741650	K562	blood:	n/a	chr2:234741633-234741641
32	CTCF	chr2:234741506-234741770	T-47D	breast:	n/a	chr2:234741633-234741641
33	CTCF	chr2:234741560-234741710	AG09309	skin:	n/a	chr2:234741633-234741641
34	CTCF	chr2:234741580-234741730	AoAF	blood vessel:	n/a	chr2:234741633-234741641
35	CTCF	chr2:234741600-234741750	BJ	skin:	n/a	chr2:234741633-234741641
36	CTCF	chr2:234741620-234741770	GM12865	blood:	n/a	chr2:234741633-234741641
37	CTCF	chr2:234741540-234741690	GM12872	blood:	n/a	chr2:234741633-234741641
38	CTCF	chr2:234741560-234741710	GM12874	blood:	n/a	chr2:234741633-234741641
39	CTCF	chr2:234741320-234741470	GM12873	blood:	n/a	n/a
40	CTCF	chr2:234741506-234741789	MCF-7	breast:	n/a	chr2:234741633-234741641
41	CTCF	chr2:234741540-234741690	MCF-7	breast:	n/a	chr2:234741633-234741641
42	CTCF	chr2:234741520-234741670	SK-N-SH_RA	brain:	n/a	chr2:234741633-234741641
43	CTCF	chr2:234740000-234740150	BE2_C	brain:	n/a	n/a
44	CTCF	chr2:234741527-234741732	K562	blood:	n/a	chr2:234741633-234741641
45	CTCF	chr2:234741840-234741990	BE2_C	brain:	n/a	n/a
46	CTCF	chr2:234726874-234726904	Hela-S3	cervix:	n/a	n/a
47	CTCF	chr2:234741480-234741630	GM12874	blood:	n/a	n/a
48	CTCF	chr2:234741520-234741670	HFF-Myc	foreskin:	n/a	chr2:234741633-234741641
49	CTCF	chr2:234741560-234741710	GM12873	blood:	n/a	chr2:234741633-234741641
50	CTCF	chr2:234741549-234741712	Kidney_OC	kidney:	n/a	chr2:234741633-234741641

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:234741670-234741720	Hela-S3	cervix:	n/a
2	chr2:234748185-234748235	HepG2	liver:	n/a
3	chr2:234745500-234745550	T-47D	breast:	n/a
4	chr2:234726683-234726733	AG04449	skin:	fetal
5	chr2:234741670-234741720	Jurkat	blood:	n/a
6	chr2:234726683-234726733	GM12878	blood:	n/a
7	chr2:234745500-234745550	NH-A	brain:	n/a
8	chr2:234741670-234741720	SK-N-SH_RA	brain:	n/a
9	chr2:234741670-234741720	HNPCEpiC	eye:	n/a
10	chr2:234726683-234726733	U87	brain:	n/a
11	chr2:234748185-234748235	MCF-7	breast:	n/a
12	chr2:234726683-234726733	AoSMC	blood vessel:	n/a
13	chr2:234741670-234741720	HEK293	kidney:	embryo
14	chr2:234726683-234726733	Hela-S3	cervix:	n/a
15	chr2:234748185-234748235	ECC-1	luminal epithelium:	n/a
16	chr2:234745500-234745550	Caco-2	colon:	n/a
17	chr2:234726683-234726733	LNCaP	prostate:	n/a
18	chr2:234741670-234741720	NH-A	brain:	n/a
19	chr2:234726683-234726733	NHDF-neo	bronchial:	n/a
20	chr2:234726683-234726733	MCF-7	breast:	n/a
21	chr2:234748185-234748235	HEEpiC	esophagus:	n/a
22	chr2:234741670-234741720	HCM	heart:	n/a
23	chr2:234748185-234748235	GM12891	blood:	n/a
24	chr2:234748185-234748235	HEK293	kidney:	embryo
25	chr2:234726683-234726733	SK-N-MC	brain:	n/a
26	chr2:234741670-234741720	A549	lung:	n/a
27	chr2:234741670-234741720	HCF	heart:	n/a
28	chr2:234745500-234745550	SK-N-SH_RA	brain:	n/a
29	chr2:234726683-234726733	HEK293	kidney:	embryo
30	chr2:234726683-234726733	H1-hESC	embryonic stem cell:	embryo
31	chr2:234748185-234748235	HAEpiC	amniotic membrane:	n/a
32	chr2:234741670-234741720	ECC-1	luminal epithelium:	n/a
33	chr2:234748185-234748235	LNCaP	prostate:	n/a
34	chr2:234726683-234726733	HAEpiC	amniotic membrane:	n/a
35	chr2:234748185-234748235	HCF	heart:	n/a
36	chr2:234741670-234741720	HL-60	blood:	n/a
37	chr2:234745500-234745550	HIPEpiC	eye:	n/a
38	chr2:234741670-234741720	AG09309	skin:	n/a
39	chr2:234748185-234748235	H1-hESC	embryonic stem cell:	embryo
40	chr2:234745500-234745550	MCF-7	breast:	n/a
41	chr2:234741670-234741720	LNCaP	prostate:	n/a
42	chr2:234726683-234726733	HUVEC	blood vessel:	n/a
43	chr2:234741670-234741720	IMR90	lung:	fetal
44	chr2:234745500-234745550	PFSK-1	brain:	n/a
45	chr2:234745500-234745550	SAEC	small airway:	n/a
46	chr2:234726683-234726733	PFSK-1	brain:	n/a
47	chr2:234726683-234726733	GM12892	blood:	n/a
48	chr2:234741670-234741720	HRPEpiC	eye:	n/a
49	chr2:234726683-234726733	GM06990	blood:	n/a
50	chr2:234726683-234726733	NB4	blood:	n/a

(count:24 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:234404504..234406876-chr2:234739242..234740869,2	MCF-7	breast:
2	chr2:234736743..234738752-chr2:234740641..234743025,2	MCF-7	breast:
3	chr2:234716641..234718534-chr2:234725162..234728143,2	MCF-7	breast:
4	chr2:234724458..234728135-chr2:234731506..234734878,3	MCF-7	breast:
5	chr2:234744897..234747736-chr2:234753531..234755159,2	MCF-7	breast:
6	chr2:234388065..234390771-chr2:234740107..234742680,2	MCF-7	breast:
7	chr2:234741715..234743297-chr2:234743662..234746338,2	MCF-7	breast:
8	chr2:234388813..234389712-chr2:234741180..234742155,6	MCF-7	breast:
9	chr2:234730421..234733178-chr2:234750778..234754644,3	K562	blood:
10	chr2:234312633..234313516-chr2:234741267..234742065,2	MCF-7	breast:
11	chr2:234724458..234728135-chr2:234731506..234734878,3	MCF-7	breast:
12	chr2:234607784..234610773-chr2:234739083..234742311,4	MCF-7	breast:
13	chr2:234742234..234744702-chr2:234763144..234764727,2	MCF-7	breast:
14	chr2:234389169..234389811-chr2:234741540..234742123,2	MCF-7	breast:
15	2:234492023-234494396..2:234743181-234749667	Hela-S3	cervix:
16	chr2:234741715..234743297-chr2:234743662..234746338,2	MCF-7	breast:
17	chr2:234614862..234617067-chr2:234739874..234742811,2	MCF-7	breast:
18	chr2:234731393..234733731-chr2:234734895..234737840,2	MCF-7	breast:
19	chr2:234738464..234743191-chr2:234754553..234759702,7	K562	blood:
20	chr2:234160919..234163001-chr2:234739570..234741620,2	MCF-7	breast:
21	chr2:234599519..234601666-chr2:234740030..234742555,2	MCF-7	breast:
22	chr2:234725851..234728012-chr2:234729988..234731598,2	K562	blood:
23	chr2:234357692..234358639-chr2:234741167..234741785,3	MCF-7	breast:
24	chr2:234725851..234728012-chr2:234729988..234731598,2	K562	blood:

No data

Variant related genes	Relation type
MROH2A	TF binding region
MROH2A	CpG island
ENSG00000228949	chromatin interactions
ENSG00000123485	chromatin interactions
ENSG00000185038	chromatin interactions
ENSG00000167165	chromatin interactions
ENSG00000085982	chromatin interactions

Extended variants
information (count: 1014 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:1014 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs12476112	chr2:234726154-234726155	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs527293809	chr2:234726158-234726159	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs191043078	chr2:234726172-234726173	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs564023787	chr2:234726179-234726180	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs28900681	chr2:234726260-234726261	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs28900682	chr2:234726261-234726262	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs117077496	chr2:234726351-234726352	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs11563237	chr2:234726355-234726356	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs6752792	chr2:234726364-234726365	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs549267263	chr2:234726387-234726388	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs558939150	chr2:234726404-234726405	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs534686031	chr2:234726456-234726457	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs558176068	chr2:234726477-234726478	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs28900683	chr2:234726482-234726483	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs28900684	chr2:234726512-234726513	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs62192267	chr2:234726546-234726547	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs182638133	chr2:234726550-234726551	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs6756004	chr2:234726616-234726617	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs138469740	chr2:234726620-234726621	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs542105796	chr2:234726630-234726631	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs555691587	chr2:234726639-234726640	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs535125815	chr2:234726669-234726670	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs572417062	chr2:234726698-234726699	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs541006233	chr2:234726712-234726713	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs11563236	chr2:234726725-234726726	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs535812122	chr2:234726726-234726727	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs532856340	chr2:234726770-234726771	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs186106859	chr2:234726771-234726772	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs28946899	chr2:234726789-234726790	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs529453595	chr2:234726803-234726804	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs549203825	chr2:234726805-234726806	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs566027044	chr2:234726827-234726828	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs554668475	chr2:234726843-234726844	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs28900685	chr2:234726844-234726845	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs368384159	chr2:234726845-234726846	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs551468333	chr2:234726862-234726863	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs571630210	chr2:234726893-234726894	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs142769104	chr2:234726904-234726905	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs28900686	chr2:234726905-234726906	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs74840034	chr2:234726918-234726919	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs567802660	chr2:234726935-234726936	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs13425899	chr2:234726966-234726967	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs545531407	chr2:234726969-234726970	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs553920847	chr2:234727000-234727001	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs572354810	chr2:234727043-234727044	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs541355018	chr2:234727049-234727050	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs137926604	chr2:234727063-234727064	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs577571906	chr2:234727100-234727101	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs112204594	chr2:234727110-234727111	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs563385929	chr2:234727119-234727120	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cervical cancer	21062161	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Chordoma	18071362	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Cancer	22429812	CNVD
Bladder cancer	21909424	CNVD
Renal cell carcinoma	21668985	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Wilms tumour	21544195	CNVD
prenatal diagnosis	22389664	CNVD
Myelofibrosis	22110671	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Mental retardation	20152051	CNVD
Cancer	21183584	CNVD
Albright''s disease	22277900	CNVD
Brachydactyly-Mental Retardation Syndrome	22470819	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Colorectal cancer	19359472	CNVD
Autism	18414403	CNVD
Chronic myeloid leukemia	21384125	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:383 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:234713200-234731400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr2:234723600-234726200	Enhancers	HSMMtube	muscle
3	chr2:234724400-234727200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
4	chr2:234724800-234726600	Enhancers	Fetal Brain Male	brain
5	chr2:234724800-234727200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
6	chr2:234725000-234727600	Enhancers	Fetal Intestine Large	intestine
7	chr2:234725000-234728000	Enhancers	Fetal Intestine Small	intestine
8	chr2:234725200-234726600	Enhancers	Fetal Muscle Trunk	muscle
9	chr2:234725200-234727000	Enhancers	A549	lung
10	chr2:234725200-234727200	Enhancers	Adipose Nuclei	Adipose
11	chr2:234725400-234726400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
12	chr2:234725600-234726200	Enhancers	Fetal Lung	lung
13	chr2:234725600-234726600	Enhancers	Placenta	Placenta
14	chr2:234725800-234727600	Bivalent Enhancer	HepG2	liver
15	chr2:234726200-234727000	Enhancers	Duodenum Mucosa	Duodenum
16	chr2:234726200-234728400	Weak transcription	HSMMtube	muscle
17	chr2:234726600-234727400	Weak transcription	Placenta	Placenta
18	chr2:234726600-234727800	Enhancers	Liver	Liver
19	chr2:234726800-234727000	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
20	chr2:234727000-234727200	Enhancers	Esophagus	oesophagus
21	chr2:234727000-234728600	Weak transcription	Duodenum Mucosa	Duodenum
22	chr2:234727000-234731400	Weak transcription	A549	lung
23	chr2:234727200-234728600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
24	chr2:234727200-234728800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
25	chr2:234727400-234727600	Enhancers	Placenta	Placenta
26	chr2:234727800-234730000	Weak transcription	Liver	Liver
27	chr2:234728000-234731000	Weak transcription	Fetal Intestine Small	intestine
28	chr2:234728600-234728800	Enhancers	Duodenum Mucosa	Duodenum
29	chr2:234728800-234729000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
30	chr2:234728800-234729000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
31	chr2:234728800-234729000	Enhancers	HSMMtube	muscle
32	chr2:234728800-234729600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
33	chr2:234728800-234729600	Bivalent Enhancer	Placenta	Placenta
34	chr2:234729000-234729200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
35	chr2:234729000-234729200	Bivalent Enhancer	Right Ventricle	heart
36	chr2:234730000-234730800	Enhancers	Liver	Liver
37	chr2:234730000-234732200	Enhancers	Duodenum Mucosa	Duodenum
38	chr2:234730800-234732000	Flanking Active TSS	Liver	Liver
39	chr2:234731000-234731800	Enhancers	Fetal Intestine Small	intestine
40	chr2:234731200-234731400	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
41	chr2:234731400-234731600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
42	chr2:234731400-234731800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr2:234731400-234733400	Enhancers	A549	lung
44	chr2:234731600-234732200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
45	chr2:234731800-234732000	Enhancers	Primary neutrophils fromperipheralblood	blood
46	chr2:234731800-234732200	Enhancers	Primary monocytes fromperipheralblood	blood
47	chr2:234731800-234732200	Bivalent Enhancer	HepG2	liver
48	chr2:234731800-234741200	Weak transcription	Fetal Intestine Small	intestine
49	chr2:234732000-234732400	Enhancers	Stomach Mucosa	stomach
50	chr2:234732000-234733400	Enhancers	Liver	Liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links